Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice

Evidence and guidelines are becoming increasingly clear about imbalance between the risks and benefits of inhaled corticosteroids (ICSs) in patients with COPD. While selected patients may benefit from ICS-containing regimens, ICSs are often inappropriately prescribed with – according to Belgian mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Cataldo, Didier, Derom, Eric, Liistro, Giuseppe, Marchand, Eric, Ninane, Vincent, Peché, Rudi, Slabbynck, Hans, Vincken, Walter, Janssens, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039066/
https://www.ncbi.nlm.nih.gov/pubmed/30013336
http://dx.doi.org/10.2147/COPD.S164259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039066/
https://www.ncbi.nlm.nih.gov/pubmed/30013336
http://dx.doi.org/10.2147/COPD.S164259

Ejemplares similares